Coaxial-Nanocables Constructed Flexible Aptasensor for Ultrafast Blood-Drop Detection of Prostate Cancer.

Small

State Key Laboratory of Materials-Oriented Chemical Engineering, College of Chemical Engineering, Nanjing Tech University, Nanjing, 211816, P. R. China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Prostate cancer (PCa) is the second most common cancer for male health with ultrahigh recurrence rates to cause high mortality. However, clinical imaging and biopsy techniques suffer the bulky testing equipment and high cost, and blood assay requires blood pretreatment before analysis to significantly restrict home-in self-examination and postoperative follow-up of PCa. Herein, a blood-drop 4-min-test technique is designed to precisely screen PCa by a high-ordered coaxial-nanocables-based aptasensor. The electrospinning potential is employed as the driving force to regulate the distribution of mixed reduced graphene oxide and polyacrylonitrile from disorder to highly order to large-scale weave coaxial nanocables-based films. This architecture has contributed abundant active DNA bonding sites and served as 3D network electron transmission channels to dramatically amplify detection signals with short response time. Moreover, a target-induced chain release strategy is implemented to precisely capture the PCa biomarker. Furthermore, a household PCa analyzer is developed to achieve ultrafast, precise, and nonhospital assays of clinical patients within 4 min which is 30 times faster than the state-of-the-art commercial instruments. This high-performance analyzer has great potential for early screening and prognostic evaluation of PCa to benefit real-time tests for both in-hospital and nonhospital patients.

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.202504714DOI Listing

Publication Analysis

Top Keywords

prostate cancer
8
pca
6
coaxial-nanocables constructed
4
constructed flexible
4
flexible aptasensor
4
aptasensor ultrafast
4
ultrafast blood-drop
4
blood-drop detection
4
detection prostate
4
cancer prostate
4

Similar Publications

Prostate cancer and inflammation mechanism are closely related because chronic inflammation causes inflammatory cells to infiltrate into prostatic atrophy areas and proliferative inflammatory atrophy is accepted as the initiator of prostate cancer. The study included 90 patients (28 patients with benign prostatic hyperplasia (BPH), 35 patients with localized prostate cancer (LPCa), and 27 patients with metastatic prostate cancer (MPCa) and 90 healthy controls. Blood samples from 90 patients and 90 healthy people were used to isolate genomic DNA.

View Article and Find Full Text PDF

Nanomedicine-Mediated Therapies to Target Cancer Stem Cells: An Emerging Technology.

Crit Rev Ther Drug Carrier Syst

January 2025

Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India.

Cancer stem cells (CSCs) are a category of cancer cells endowed with the ability to renew themselves, undergo unregulated growth, and exhibit a differentiation capacity akin to that of normal stem cells. CSCs have been linked with tumor metastasis and cancer recurrence due to their ability to elude immune monitoring. As a result, targeting CSCs specifically may improve the efficacy of cancer therapy.

View Article and Find Full Text PDF

Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.

Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.

View Article and Find Full Text PDF

A new frontier in oncology: Understanding the landscape of cancer vaccines.

J Oncol Pharm Pract

September 2025

Department of Research & Development, Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh, India.

Cancer vaccines represent a transformative shift in oncology, aiming to prevent malignancies or treat established cancers by training the immune system to recognize tumor-specific or tumor-associated antigens. This review explores the diverse platforms and mechanisms supporting cancer vaccines, ranging from prophylactic vaccines such as HPV and hepatitis B vaccines that have significantly reduced virus-related cancers to therapeutic vaccines like Sipuleucel-T and T-VEC that extend survival in prostate cancer and melanoma. Vaccine types are classified, and delivery platforms including mRNA, peptide, dendritic cell and viral vector-based approaches are examined alongside pivotal clinical trial outcomes.

View Article and Find Full Text PDF

Age is a major risk factor for a range of diseases including prostate cancer. Understanding how age influences the susceptibility of normal prostate epithelial cells to cancer initiation is complicated by the fact that aging affects all tissues in the body. Assessing how various aging mechanisms influence the prostate epithelium is a necessary step to determine the critical factors associated with aging that increase prostate cancer risk.

View Article and Find Full Text PDF